2.4 Impaired Pharmacists, KYPRN & Reporting Duties

2.4 Impaired Pharmacists, KYPRN & Reporting Duties

Competency Statement 1.2 of the MPJE blueprint expressly includes "reporting to and participating in programs addressing the inability to practice with reasonable skill and safety." Kentucky answers that statement with a two-track system: a disciplinary track run by the Board under KRS 315.121, and a recovery track run through the Pharmacist Recovery Network Committee (PRNC) and the Kentucky Professionals Recovery Network (KYPRN). Knowing which track a fact pattern belongs to is the whole exam skill here.

---

1. The Statutory Ground: Inability to Practice Safely

KRS 315.121 lists the grounds on which the Board may discipline a licensee, permit holder, or registrant. Impairment sits at KRS 315.121(1)(d) — the inability to practice pharmacy with reasonable skill and safety because of illness, excessive use of alcohol or drugs, or a physical or mental condition.

Two features of this ground matter on the exam:

1. Impairment is not a finding of misconduct. A pharmacist can be impaired without having diverted a single tablet. The Board's interest is prospective patient safety, not punishment, which is why Kentucky built a diversionary recovery pathway rather than treating every case as a discipline case.
2. Impairment and diversion frequently travel together, but they are separate grounds. Self-administering controlled substances taken from the pharmacy's stock triggers both the impairment ground and recordkeeping, theft-reporting, and controlled substance grounds. A candidate who answers only "refer to KYPRN" on a fact pattern involving stolen inventory has missed the DEA Form 106 theft/loss report and the Board complaint.

---

2. The Pharmacist Recovery Network Committee (KRS 315.126 / 201 KAR 2:250)

KRS 315.126(1) requires the Board of Pharmacy to establish a pharmacist recovery network committee. 201 KAR 2:250 sets the minimum requirements for how the PRNC is constituted and operated, and defines how the Board's PRNC consultant works with the Board on intervention, evaluation, treatment, and continuing care and monitoring through a treatment provider. 201 KAR 2:195 (Impaired pharmacists) is the companion regulation.

┌─────────────────────────────────────────────────────────────────────────────┐
│              KENTUCKY IMPAIRMENT: THE TWO ENTRY POINTS                      │
├─────────────────────────────────────────────────────────────────────────────┤
│ ENTRY POINT 1 — SELF-REPORT                                                 │
│  • A pharmacist or pharmacist intern self-reports impairment resulting from │
│    the misuse or abuse of alcohol or drugs, or both.                        │
│  • Handled through the PRNC consultant, who arranges evaluation, treatment, │
│    continuing care, and monitoring through a treatment provider.            │
│  • This is the pathway that preserves the most confidentiality and the most │
│    control over the licensee's own outcome.                                 │
│                                                                             │
│ ENTRY POINT 2 — THIRD-PARTY REPORT OR BOARD REFERRAL                        │
│  • A colleague, PIC, employer, family member, or inspector reports concern; │
│    or a Board case is opened and referred to the PRNC.                      │
│  • The PRNC reviews cases BEFORE the licensee appears before the Board for  │
│    license action — it is a screening and diversion body, not a court.      │
└─────────────────────────────────────────────────────────────────────────────┘

Confidentiality of the Consultant's Records

201 KAR 2:250 restricts the consultant's record-copying: the consultant may not make copies or reports of records that do not concern the licensee's impairment and participation in treatment. This is the regulation's answer to the obvious deterrent problem — a licensee will not self-report into a program whose consultant can hand the Board an unbounded file.

KYPRN — the Operating Program

KYPRN (Kentucky Professionals Recovery Network) is the free-standing organization that delivers the monitoring in practice. It monitors both licensees known to the Board and licensees who are not, administers recovery programs for multiple Kentucky licensing boards, and is funded by a per-license annual assessment collected by the Board. Monitoring contracts typically run three (3) to five (5) years and include random drug testing, documented recovery meeting attendance, and a workplace practice monitor.

---

3. Who Must Report, and to Whom

Exam Trap — "confidential" does not mean "no consequences." Self-reporting and entering a monitoring contract does not erase an independent violation. If the pharmacist diverted controlled substances, the theft/loss report to DEA and the pharmacy's own inventory reconciliation obligations are unaffected by the recovery referral. Items are written to see whether a candidate stops at "refer to the recovery program."

---

4. Where Discipline Goes After the Recovery Track

If a licensee declines the recovery pathway, is ineligible for it, or breaches a monitoring contract, the case moves into the ordinary disciplinary machinery:

• 201 KAR 2:061 sets the procedures the Board follows in investigating and hearing complaints, including case review before formal action.
• Sanctions under KRS 315.121 run from reprimand and probation with practice restrictions, through suspension, to revocation, with civil penalties available.
• 201 KAR 2:270 (Expungement) allows a licensee to petition for expungement of minor discipline after a qualifying period of clean practice — the mechanism that keeps a single resolved impairment episode from following a recovered pharmacist permanently.
• 201 KAR 2:025 (License reinstatement) governs return to practice after a revoked or lapsed license.

Exam Trap — the impairment ground is not limited to substance use. KRS 315.121(1)(d) reaches any condition that renders the licensee unable to practise with reasonable skill and safety, including physical illness and cognitive decline. A fact pattern about a pharmacist with advancing dementia who has never used a substance still fits the ground — though the KYPRN monitoring model, which is built for substance use disorders, may not be the Board's remedy.